Dexcom has received U.S. Food and Drug Administration (FDA) clearance for the G7 15-day continuous glucose monitoring (CGM) system for adults with diabetes.
According to the company, it’s the longest lasting CGM system with 15.5 days of wear. It boasts an overall MARD (mean absolute relative difference) of 8% and easier glucose management with fewer monthly sensors and reduced monthly waste.
Dexcom said it’s working with its insulin pump partners to make sure the G7 15-day will be compatible with automated insulin delivery (AID) systems upon its launch. G7 is currently compatible with the Omnipod 5 AID and t:slim X2 insulin pump.
The rollout is anticipated in the U.S. in the second half of 2025.
https://www.mpo-mag.com/breaking-news/fda-oks-dexcom-g7-15-day-continuous-glucose-monitor/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.